Division of Infectious Diseases, New York State Department of Health, Wadsworth Center, Albany, New York, USA.
Department of Biomedical Sciences, University at Albany, Albany, New York, USA.
Infect Immun. 2024 Apr 9;92(4):e0008424. doi: 10.1128/iai.00084-24. Epub 2024 Mar 12.
Camelid-derived, single-domain antibodies (VHs) have proven to be extremely powerful tools in defining the antigenic landscape of immunologically heterogeneous surface proteins. In this report, we generated a phage-displayed VH library directed against the candidate Lyme disease vaccine antigen, outer surface protein A (OspA). Two alpacas were immunized with recombinant OspA serotype 1 from strain B31, in combination with the canine vaccine RECOMBITEK Lyme containing lipidated OspA. The phage library was subjected to two rounds of affinity enrichment ("panning") against recombinant OspA, yielding 21 unique VHs within two epitope bins, as determined through competition enzyme linked immunosorbent assays (ELISAs) with a panel of OspA-specific human monoclonal antibodies. Epitope refinement was conducted by hydrogen exchange-mass spectrometry. Six of the monovalent VHs were expressed as human IgG1-Fc fusion proteins and shown to have functional properties associated with protective human monoclonal antibodies, including agglutination, outer membrane damage, and complement-dependent borreliacidal activity. The VHs displayed unique reactivity profiles with the seven OspA serotypes associated with genospecies in the United States and Europe consistent with there being unique epitopes across OspA serotypes that should be considered when designing and evaluating multivalent Lyme disease vaccines.
骆驼科来源的单域抗体(VHs)已被证明是定义免疫异质表面蛋白抗原表位的极其强大的工具。在本报告中,我们针对候选莱姆病疫苗抗原外表面蛋白 A(OspA)生成了一个噬菌体展示 VH 文库。两只羊驼用来自菌株 B31 的重组 OspA 血清型 1和含有脂化 OspA 的犬用疫苗 RECOMBITEK Lyme 进行免疫。将噬菌体文库针对重组 OspA 进行两轮亲和富集(“淘选”),通过与一组 OspA 特异性人源单克隆抗体的竞争酶联免疫吸附测定(ELISA)确定了两个表位仓内的 21 个独特的 VH。通过氢交换-质谱进行表位精修。六个单价 VH 被表达为人 IgG1-Fc 融合蛋白,并显示出与保护性人源单克隆抗体相关的功能特性,包括凝集、外膜损伤和补体依赖性杀伯氏疏螺旋体活性。VH 与与美国和欧洲的种系相关的七种 OspA 血清型显示出独特的反应性谱,这表明在设计和评估多价莱姆病疫苗时,应该考虑到 OspA 血清型之间存在独特的表位。